Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 30;12(8):1258.
doi: 10.3390/jpm12081258.

Management of the Two-Week Wait Pathway for Skin Cancer Patients, before and during the Pandemic: Is Virtual Consultation an Option?

Maria-Roxana Chiru  1 , Sandip Hindocha  1 , Ekaterina Burova  2 , Gabriel-Cristian Bejan  3 , Laura-Maria Manea  4 , Liviu-Nicolae Ghilencea  3
Affiliations

Management of the Two-Week Wait Pathway for Skin Cancer Patients, before and during the Pandemic: Is Virtual Consultation an Option?

Maria-Roxana Chiru et al. J Pers Med. .

Abstract

Background: Although telemedicine emerged more than 100 years ago, the recent pandemic underlined the role of remote assessment of different diseases. The diagnoses of cutaneous conditions, especially malignant lesions, have placed significant stress on the fast-track pathway for general practitioners (GPs), dermatologists, and plastic surgeons. The aim of the study was to compare (pre- and during the pandemic) the ability of professionals to face the challenge.

Methods: The study was composed of 1943 consecutive patients (mean age 61.9 ± 18.3, 53.8% female) assessed by GPs, face-to-face (988 patients, 50.8%, between October 2019 and March 2020) and by virtual (video/photo) visits (955 patients, 49.2%, between March 2020 and October 2020) for skin lesions, and referred to secondary care via the two-week wait pathway for suspected skin malignancy.

Results: The two groups had similar primary skin malignancies identification rates (24.3% vs. 22.1%, p = 0.25). The virtual visits identified squamous cell carcinoma (SCC) better than face-to-face consultations (p = 0.04), but identified basal cell carcinoma less-well (BCC, p = 0.02), whereas malignant melanoma (MM) was equally identified in the two groups (p = 0.13). There was no difference in the median breach time (days) of the two-week wait pathway (12, IQR = 6 vs. 12, IQR = 5, p = 0.16) in the two groups. Virtual assessments (by GPs) of skin lesions suspected of malignancy, and referred via the two-week wait pathway, increased the probability of diagnosing SCC by 42.9% (p = 0.03), while for malignant melanomas, face-to-face and virtual consultations were alike (p = 0.12).

Conclusions: The equivalent outcomes in the management of skin cancers (SCC, MM) via the two-week pathway through virtual consultations and face-to-face appointments underline the role of telemedicine as a reliable alternative to face-to-face assessments.

Keywords: basal cell carcinoma; malignant melanoma; skin cancer; squamous cell carcinoma; telemedicine; two-week wait pathway; video consultation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flowchart of the study. GP, general practitioner; AP, anatomopathology; SC, squamous cell; BC, basal cell.
Figure 2
Figure 2
Forest plot for the face-to-face (left) and virtual video/photo consultation (right).
See this image and copyright information in PMC

References

    1. Green A.C., Baade P., Coory M., Aitken J.F., Smithers M. Population-Based 20-Year Survival among People Diagnosed with Thin Melanomas in Queensland, Australia. J. Clin. Oncol. 2012;30:1462–1467. doi: 10.1200/JCO.2011.38.8561. - DOI - PubMed
    1. Lomas A., Leonardi-Bee J., Bath-Hextall F. A Systematic Review of Worldwide Incidence of Nonmelanoma Skin Cancer. Br. J. Dermatol. 2012;166:1069–1080. doi: 10.1111/j.1365-2133.2012.10830.x. - DOI - PubMed
    1. Overview: Suspected Cancer: Recognition and Referral: Guidance. [(accessed on 19 June 2022)]. NICE. Available online: https://www.nice.org.uk/guidance/ng12.
    1. Ayda H.-R., Johanna O. Diagnostic Accuracy amongst Two Week Wait Referrals for Skin Malignancy. J. Dermatol. Res. Ther. 2021;7:111. doi: 10.23937/2469-5750/1510111. - DOI
    1. Piccolo D., Smolle J., Wolf I.H., Peris K., Hofmann-Wellenhof R., Dell’Eva G., Burroni M., Chimenti S., Kerl H., Soyer H.P. Face-To-Face Diagnosis vs. Telediagnosis of Pigmented Skin Tumors. Arch. Dermatol. 1999;135:1467–1471. doi: 10.1001/archderm.135.12.1467. - DOI - PubMed